| # | Drug | Count |
|---|---|---|
| 0 | LAMIVUDINE | 53 |
| 1 | LAMIVUDINE ORAL | 53 |
| 2 | EFAVIRENZ | 32 |
| 3 | TENOFOVIR DISOPROXIL FUMARATE | 24 |
| 4 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 24 |
| 5 | FOLIC ACID | 11 |
| 6 | ADALIMUMAB | 9 |
| 7 | ISOPROPYL ALCOHOL | 9 |
| 8 | ALCOHOL | 8 |
| 9 | ETHYL ALCOHOL | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ARTEMETHER AND LUMEFANTRINE | 1 | 0.0051 |
| 1 | PRAZIQUANTEL | 1 | 0.0033 |
| 2 | EFAVIRENZ | 32 | 0.0029 |
| 3 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 24 | 0.0028 |
| 4 | PONESIMOD | 1 | 0.0023 |
| 5 | LAMIVUDINE | 53 | 0.0021 |
| 6 | HALOBETASOL PROPIONATE | 2 | 0.0015 |
| 7 | MECASERMIN | 1 | 0.0012 |
| 8 | ATOVAQUONE AND PROGUANIL HYDROCHLORIDE | 2 | 0.0009 |
| 9 | SODIUM CITRATE | 1 | 0.0008 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 38 | 0.0016 |
| 1 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 56 | 0.0011 |
| 2 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 56 | 0.0005 |
| 3 | Anthelmintic [EPC] | 1 | 0.0003 |
| 4 | Calcitonin [EPC] | 1 | 0.0003 |
| 5 | Antimalarial [EPC] | 3 | 0.0003 |
| 6 | Progesterone [EPC] | 6 | 0.0003 |
| 7 | Vitamin K [EPC] | 2 | 0.0002 |
| 8 | Antiprotozoal [EPC] | 2 | 0.0002 |
| 9 | Vitamin D Analog [EPC] | 2 | 0.0001 |